Mevia - Chalmers Ventures
chalmers ventures portfolio company


50 % of patients do not follow their treatment as prescribed, which can dangerously affect their health, but also ends up weighing heavy on everyone’s budget in the health-care sector. Mevia strives to boost medication adherence worldwide with connected solutions that adapt to patient needs and medication formats, as well as data analytics services. Mevia solutions enhance treatment outcomes, increase revenues of healthcare providers and enable high healthcare savings within society.